Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

JCR. 2020; 7(17): 2994-3004


ANTI-PARKINSON'S ACTIVITY OF EMBLICA OFFICINALIS AND TERMINALIA BELLIRICA

Himani Badoni, Promila Sharma, Manoj K. Pal, Kumud Pant, Bhawana, Neetu Sharma, Nilay Singh, Syed Mohsin Waheed, Prof Dr. Bindu Agarwal.

Abstract
In the present study, methanolic extracts of fruits of Emblica officinalis (EOM) and Terminalia
bellirica (TBM) were screened for their anti-Parkinson's activity. Haloperidol (1 mg kg-1) was given to male
Wistar rats to induce catalepsy and Parkinsonís disease-like symptoms. Effect of EOM and TBM (300 mg kg-1,
p.o.) pretreatment was observed on behavioural parameter like catalepsy and biochemical parameters like lipid
peroxidation (LPO), glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD). The increased
cataleptic score induced by haloperidol was found to be significantly reduced with the EOM and TBM
pretreatment given orally for five days each at a dose of 300 mg kg-1. Haloperidol treatment showed significant
increase in lipid peroxidation level and depleted superoxide dismutase, catalase, and glutathione levels, whereas
daily administration of EOM and TBM (300 mg kg-1, p.o.) significantly attenuated lipid peroxidation level and
enhanced superoxide dismutase, catalase, and glutathione levels. Thus, the study demonstrates that EOM and
TBM treatments significantly attenuate the symptoms of catalepsy and protects the brain from oxidative stress
by modulation of oxidative stress markersí profile.

Key words: Parkinsonís disease, haloperidol, catalepsy, oxidative stress



Similar Articles

Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMedģ Information Services.



ScopeMed Web Sites